Ulta Beauty stock jumped on Q2 earnings

By: Miguel A. Rodriguez

16:05, 26 August 2021

1629982145.jpg
The largest beauty retailer in the US selling both mass and prestige cosmetics delivered higher-than-expected figures for the fiscal second quarter of 2021

Ulta Beauty reported an EPS of $4.56 on revenues of $1.97 billion. Both figures topped the $2.59 earnings per share and $1.76 billion revenue estimate. The revenue beat was driven by a 52.5% increase in transactions and a 26.7% growth in how much people spent on average.

“This performance reflects the recovery of the beauty category, investments and choices we’ve made over the last year to adapt to the market disruption and strengthen our leadership position, and the ongoing efforts of our associates to deliver great experiences for our guests,” stated Dave Kimbell, Ulta Beauty CEO.

The retailer opened seven new stores during the quarter and closed one, planning to open 44 net new others this year.

As expected, the store traffic in the quarter was higher than what Ulta reported in Q1. Still, it lagged behind 2019 levels. Moreover, e-commerce sales fell from the year-ago period, as COVID-19 restrictions eased and vaccinated customers became more comfortable shopping in person.

For the full year, Ulta expects sales figures to come in at a high of $8.3 billion, with an EPS as high as $14.70.

After the news hit the wires, Ulta shares rose more than 5%, jumping to a 52-week high. Year to date, the company’s stock price went up 36%, pushing the market cap at nearly $21.4 billion.

 

Sources: cnbc.com, thestreet.com

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.